Informações:
Falhas:
ID
22075
Descrição
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00415363
Link
https://clinicaltrials.gov/show/NCT00415363
Palavras-chave
Versões (1)
- 18/05/2017 18/05/2017 -
Transferido a
18 de maio de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Non Small Cell Lung Cancer NCT00415363
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Lung Carcinoma Metastatic in the Brain
Item
having radiologically proven brain metastases of lung cancer
boolean
C1334441 (UMLS CUI [1])
Whole brain radiotherapy | Gray unit of radiation dose Quantity Week Quantity | enzastaurin
Item
having received whole brain radiotherapy with either 30 grays in 2 weeks or 20 grays in one week. treatment with enzastaurin must start within 14 days after the last fraction of the whole brain radiotherapy
boolean
C1520143 (UMLS CUI [1])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
Radiotherapy to brain | Radiosurgery Quantity
Item
no other previous radiotherapy to the brain except for radiosurgery at one occasion
boolean
C0948319 (UMLS CUI [1])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Organ function Laboratory Procedures
Item
adequate organ function as measured by appropriate laboratory tests.
boolean
C0678852 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Able to swallow Tablets | Condition Interferes with Oral medication administration | Vomiting | Partial bowel obstruction
Item
inability to swallow tablets or show conditions which could interfere with oral medication intake (e.g. vomiting, partial bowel obstruction).
boolean
C2712086 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
Antiepileptic Agents Unable to discontinue | Carbamazepine | Phenobarbital | Phenytoin
Item
inability to discontinue use of certain anti-epileptic drugs such as, carbamazepine, phenobarbital or phenytoin.
boolean
C0003299 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
Warfarin
Item
concurrent administration of warfarin
boolean
C0043031 (UMLS CUI [1])
Hemophilia
Item
hemophilia
boolean
C0684275 (UMLS CUI [1])
Cancer treatment Systemic
Item
having had any systemic anti-cancer treatment within the last 2 weeks prior to enrolment.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])